Daniel Ferreira
Overview
Explore the profile of Daniel Ferreira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
190
Citations
2694
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adewale Q, Khan A, Lin S, Baumeister T, Zeighami Y, Carbonell F, et al.
NPJ Parkinsons Dis
. 2025 Feb;
11(1):29.
PMID: 39952947
We continue to lack a clear understanding on how the biological and clinical complexity of Parkinson's disease emerges from molecular to macroscopic brain interactions. Here, we use personalized multiscale spatiotemporal...
2.
Ferreira D, Przybelski S, Lesnick T, Diaz-Galvan P, Schwarz C, Murray M, et al.
JAMA Neurol
. 2025 Jan;
82(3):285-294.
PMID: 39804619
Importance: Although 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a well-established cross-sectional biomarker of brain metabolism in dementia with Lewy bodies (DLB), the longitudinal change in FDG-PET has not been characterized....
3.
Wyman-Chick K, Bayram E, Gravett S, DAntonio F, Rodriguez-Porcel F, Kane J, et al.
Alzheimers Dement
. 2025 Jan;
21(2):e14450.
PMID: 39791487
Background: We sought to characterize the cognitive profile among individuals with mild cognitive impairment with Lewy bodies (MCI-LB) to help guide future clinical criteria. Methods: Systematic review and meta-analysis included...
4.
Patients with dementia with Lewy bodies display a signature alteration of their cognitive connectome
Yanez-Perez R, Garcia-Cabello E, Habich A, Cedres N, Diaz-Galvan P, Abdelnour C, et al.
Sci Rep
. 2025 Jan;
15(1):940.
PMID: 39762366
Cognition plays a central role in the diagnosis and characterization of dementia with Lewy bodies (DLB). However, the complex associations among cognitive deficits in different domains in DLB are largely...
5.
Wheatley S, Mohanty R, Poulakis K, Levin F, Muehlboeck J, Nordberg A, et al.
Brain Commun
. 2024 Dec;
6(6):fcae426.
PMID: 39703327
[F] fluorodeoxyglucose (FDG)-PET and MRI are key imaging markers for neurodegeneration in Alzheimer's disease. It has been well established that parieto-temporal hypometabolism on FDG-PET is closely associated with medial temporal...
6.
Grine M, Guerreiro C, Costa F, Nobre Menezes M, Ladeiras-Lopes R, Ferreira D, et al.
Rev Port Cardiol
. 2024 Oct;
44(2):107-119.
PMID: 39393635
Digital health interventions including telehealth, mobile health, artificial intelligence, big data, robotics, extended reality, computational and high-fidelity bench simulations are an integral part of the path toward precision medicine. Current...
7.
Gonzalez-Burgos L, Lozano-Rodriguez C, Molina Y, Garcia-Cabello E, Aciego R, Barroso J, et al.
Front Psychol
. 2024 Oct;
15:1407583.
PMID: 39355297
Objectives: We aimed to advance our understanding of the effect of chess on cognition by expanding previous univariate studies with the use of graph theory on cognitive data. Specifically, we...
8.
Rennie A, Ekman U, Shams S, Ryden L, Samuelsson J, Zettergren A, et al.
Brain Commun
. 2024 Sep;
6(5):fcae290.
PMID: 39291165
Co-pathologies are common in dementia with Lewy bodies and other dementia disorders. We investigated cerebrovascular and Alzheimer's disease co-pathologies in patients with dementia with Lewy bodies in comparison with patients...
9.
Habich A, Garcia-Cabello E, Abbatantuono C, Gonzalez-Burgos L, Taurisano P, Dierks T, et al.
Geroscience
. 2024 Aug;
PMID: 39210164
During ageing, different cognitive functions decline at different rates. Additionally, cognitive reserve may influence inter-individual variability in age-related cognitive decline. These complex relationships can be studied by constructing a so-called...
10.
Xu H, Habich A, Ferreira D, Elisabet L, Westman E, Eriksdotter M
Alzheimers Dement
. 2024 Aug;
20(10):6740-6754.
PMID: 39177108
Introduction: We aimed to assess the impact of cholinesterase inhibitors (ChEIs) and memantine on cognition, major adverse cardiovascular events (MACE) and mortality in dementia with Lewy bodies (DLB). Methods: A...